IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas-Reference-Cited by-同舟云学术

IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas

Published:2005-01 Issue:12 Volume:46 Page:1743-1748
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Park B. -B.,Kim W. S.,Lee J.,Park K. W.,Kang J. -H.,Lee S. -H.,Park J. O.,Kim K.,Jung C. W.,Park Y. S.,Im Y. -H.,Kang W. K.,Ko Y. -H.,Lee M. H.,Park K.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190500178266

Reference16 articles.

1. Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification

2. Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification

3. New insights into peripheral T-cell lymphomas

4. IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphomas as Front-Line Consolidation or in the Relapsed/Refractory Setting: A Systematic Review/Meta-Analysis;Biology of Blood and Marrow Transplantation;2016-05

2. Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability;Annals of Hematology;2016-01-04

3. Treatment outcomes of IMEP as a front-line chemotherapy for patients with peripheral T-cell lymphomas;Blood Research;2016

4. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center;Annals of Hematology;2013-03-27

5. Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity;Investigational New Drugs;2010-08-24